It has been observed that nimotuzumab enhances the radiosensitivity of tumor cells in lung and breast cancer by blocking nuclear translocation in EGFR and inhibiting repair caused by radiation-induced DNA damage (8, 16). The gene discussed is EGFR; the disease is breast carcinoma.